CK7( [4-(2-Amino-4-methyl-thiazol-5-YL)-pyrimidin-2-YL]-(3-nitro-phenyl)-amine )

Catalog No. M28803 CAS No. 507487-89-0

CK7, a Cdk2/9 inhibitor, can be used for the synthesis of Nek1 inhibitor BSc5231 and BSc5367.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	128	In Stock
5MG	117	In Stock
10MG	187	In Stock
25MG	376	In Stock
50MG	576	In Stock
100MG	886	In Stock
200MG	1190	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

CK7
Note

Research use only, not for human use.
Brief Description

CK7, a Cdk2/9 inhibitor, can be used for the synthesis of Nek1 inhibitor BSc5231 and BSc5367.
Description

CK7, a Cdk2/9 inhibitor, can be used for the synthesis of Nek1 inhibitor BSc5231 and BSc5367.
In Vitro

——
In Vivo

——
Synonyms

[4-(2-Amino-4-methyl-thiazol-5-YL)-pyrimidin-2-YL]-(3-nitro-phenyl)-amine
Pathway

Angiogenesis
Target

CDK
Recptor

Δ5D
Research Area

——
Indication

——

Chemical Information

CAS Number

507487-89-0
Formula Weight

655.69
Molecular Formula

C28H23N12O4S2
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 12.5 mg/mL (38.07 mM)
SMILES

Cc1c(-c2nc(Nc3cc([N+]([O-])=O)ccc3)ncc2)sc(N)n1Cc1c(-c2nc(Nc3cc([N+]([O-])=O)ccc3)ncc2)sc(N)n1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.T-3364366 Targets the Desaturase Domain of Delta-5 Desaturase with Nanomolar Potency and a Multihour Residence Time Ikuo Miyahisa, Hideo Suzuki, Atsushi Mizukami, Yukiya Tanaka, Midori Ono, Mark S. Hixon, and Junji Matsui Publication Date (Web): August 10, 2016 (Letter)

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks